Mutations in critical domains confer the human mTOR gene strong tumorigenicity.
about
Signaling Pathways in Thyroid Cancer and Their Therapeutic ImplicationsDevelopment of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolutionExome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR.miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTORLow glucose dependent decrease of apoptosis and induction of autophagy in breast cancer MCF-7 cells.mTOR pathway in colorectal cancer: an update.mTOR inhibitors in urinary bladder cancer.Transforming somatic mutations of mammalian target of rapamycin kinase in human cancer.PTRF suppresses the progression of colorectal cancers.Absence of somatic mutations of the mTOR gene in differentiated thyroid cancer.Insights from yeast into whether the inhibition of heat shock transcription factor (Hsf1) by rapamycin can prevent the Hsf1 activation that results from treatment with an Hsp90 inhibitor.Invitro Evaluation of Torin2 and 2, 6-Dihydroxyacetophenone in Colorectal Cancer Therapy.Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro.
P2860
Q26764899-2C72A530-ACB3-40E5-915F-C44603D0F58BQ28655705-DBC8D1DC-7013-4BFF-AF31-C459B1B8DE1CQ30388270-24FCC5F1-502F-40CF-9ACA-D31B7BC2845EQ35639945-6AF38440-9DD2-4DB4-847F-F9CEB3C779E5Q36414487-99FCAAE5-F867-4374-B4A8-7FD294B38E81Q36952559-E5C8286C-4E1D-402F-98DD-35B1B06C9B5BQ37649634-F6455051-EF2A-4F63-86BE-9A5400790AD5Q38737064-C7A1C1CF-B53F-464D-B0A4-0DD50006620FQ40472184-1EB44CE7-C19E-437C-9F92-BCBBFF0DB220Q41472038-09EBBDB1-A914-4EB2-AD83-EF7A9E06D8A8Q41602327-B4A778B6-2C1D-4081-8DD1-0E0922C400C2Q41899062-C12C1507-6AAD-46B4-BAF3-372DC1B18DD0Q48364896-C537B828-B9A6-4407-BBC7-1B051FE0FF7DQ48850571-D857EF2E-1C93-4FAD-9ECB-546969FD24B5Q54113534-4ECAAB86-377C-4AA5-8386-A211A1D5EDCF
P2860
Mutations in critical domains confer the human mTOR gene strong tumorigenicity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Mutations in critical domains confer the human mTOR gene strong tumorigenicity.
@ast
Mutations in critical domains confer the human mTOR gene strong tumorigenicity.
@en
type
label
Mutations in critical domains confer the human mTOR gene strong tumorigenicity.
@ast
Mutations in critical domains confer the human mTOR gene strong tumorigenicity.
@en
prefLabel
Mutations in critical domains confer the human mTOR gene strong tumorigenicity.
@ast
Mutations in critical domains confer the human mTOR gene strong tumorigenicity.
@en
P2093
P2860
P356
P1476
Mutations in critical domains confer the human mTOR gene strong tumorigenicity.
@en
P2093
Ali Alzahrani
Avaniyapuram Kannan Murugan
Mingzhao Xing
P2860
P304
P356
10.1074/JBC.M112.399485
P407
P577
2013-01-15T00:00:00Z